Stock OJU ORAMED PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Insiders Oramed Pharmaceuticals, Inc. Xetra

Equities

OJU

US68403P1049

End-of-day quote Xetra
Other stock markets
- EUR - Intraday chart for Oramed Pharmaceuticals, Inc.
05-15 Compugen Names David Silberman CFO MT
05-09 Oramed Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Compugen Names David Silberman CFO
MT
Oramed Pharmaceuticals Inc. Appoints Yehuda Reznick as Director, Effective as of April 1, 2024
CI
Oramed Pharmaceuticals Inc. Announces Resignation of Yadin Rozov from the Board of Directors
CI
Oramed Pharmaceuticals Inc. Appoints Daniel Aghion as Director, Effective January 1, 2024
CI
Oramed Pharmaceuticals Inc. Appoints Ben Shapiro to Its Board of Directors
CI
Insider Buy: Oramed Pharmaceuticals
MT
Insider Sell: Oramed Pharmaceuticals
MT
Oramed Pharmaceuticals Inc. Appoints Anne Peters to Its Scientific Advisory Board
CI
Oramed Pharmaceuticals Inc Announces Appoints Yadin Rozov to Its Board of Directors
CI
Oramed Pharmaceuticals Inc. Announces the Appointment of Netanel Derovan as Chief Legal Officer (General Counsel) and Company Secretary, Effective January 9, 2022
CI
Insider Sell: Oramed Pharmaceuticals
MT
Oramed Pharmaceuticals Inc. Appoints Michael Rabinowitz as Chief Commercial Officer
CI
Oramed Pharmaceuticals Inc. Appoints David Silberman as Treasurer and Secretary, Effective July 5, 2021
CI
Oramed Pharmaceuticals Inc. Announces Resignation of Avraham Gabay as Treasurer and Secretary Effective July 5, 2021
CI
Oramed Pharmaceuticals Inc. Announces Resignation of Avraham Gabay as Chief Financial Officer, Effective July 5, 2021
CI
Oramed Appoints Dr. Julio Rosenstock to its Scientific Advisory Board
CI
Oramed Pharmaceuticals Inc. Elects Alexander Fleming to Scientific Advisory Board
CI
Oramed Pharmaceuticals Inc. Appoints Jay Skyler to Scientific Advisory Board
CI
Oramed Appoints Arie Mayer to its Board of Directors
CI
Oramed Pharmaceuticals Inc. Appoints Joshua Hexter to Serve as Chief Operating & Business Officer, Effective September 19, 2019
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ORMP Stock
  4. OJU Stock
  5. News Oramed Pharmaceuticals, Inc.
  6. Insiders